FDA.reportPublic FDA data

Clearasil ® Ultra ® Rapid Action Acne Solution System

Manufacturer
RB Health (US) LLC
Effective date
2019-08-29
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:13:50

Label at a glance#

ProductClearasil Ultra Rapid Action Acne System
Active ingredientSalicylic Acid, Benzoyl Peroxide
Label structure31 sections

Dosage and administration

use every day in the morning and evening. wet face. dispense 1 pump of wash into palm of hand. add water and gently massage onto face, avoiding eye area. rinse off thoroughly with warm water and pat dry. wash hands after use.

Storage and handling

store in a cool dry place.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Step 1: Ultra® Rapid Action Daily Face Wash

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2.0%

Purpose

OTC - PURPOSE SECTION

Acne medication

Use

INDICATIONS & USAGE SECTION

  • for daily facial cleansing.
  • for the treatment and prevention of acne.

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • avoid contact with eyes. If product gets into the eyes rinse thoroughly with water.
  • with other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one acne medication should be used unless directed by your doctor.
  • limit use to the face and neck.

OTC - STOP USE SECTION

Stop use and ask a doctor if skin or eye irritation develops.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use every day in the morning and evening.
  • wet face.
  • dispense 1 pump of wash into palm of hand.
  • add water and gently massage onto face, avoiding eye area.
  • rinse off thoroughly with warm water and pat dry.
  • wash hands after use.

Other information

STORAGE AND HANDLING SECTION

  • store in a cool dry place.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, PPG-15 Stearyl Ether, Glycerin, Stearyl Alcohol, Cetyl Betaine, Distearyldimonium Chloride, Sodium Lauryl Sulfate, Oxidized Polyethylene, Cetyl Alcohol, Alcohol, Steareth-21, Sodium Chloride, Behenyl Alcohol, PPG-30, Steareth-2, Fragrance, Menthol, Disodium EDTA, BHT.

SPL UNCLASSIFIED SECTION

Step 2: Ultra® Rapid Action Daily Toner

Warnings

WARNINGS SECTION

Don't get this toner in your eyes or mouth. If you do, rinse it out with lots of water.

OTC - STOP USE SECTION

Stop using it if skin irritation occurs. This lotion may not suit very dry skin.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

Use every day in the morning and the evening after Step 1. Moisten a cottonball and smooth over cleansed face, avoiding eye area. Do not rinse. Allow product to dry.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Alcohol Denat., Aloe Barbadensis Leaf Juice, Myrtrimonium Bromide, Ceteareth-12, Disodium Cocoamphodiacetate, Sodium Chloride, Allantoin, Chlorhexidine Digluconate, Tartaric Acid, Imidazolidinyl Urea, Methylparaben, Propylparaben.

SPL UNCLASSIFIED SECTION

Step 3: Ultra® Rapid Action Daily Lotion

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 0.5%

Purpose

OTC - PURPOSE SECTION

Acne Medication

Use

INDICATIONS & USAGE SECTION

for the treatment and prevention of acne.

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • with other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one medication should be used unless directed by your doctor.
  • avoid contact with the eyes. If product gets into eyes, rinse thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if skin or eye irritation develops.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use everyday in the morning and evening after Step 2.
  • cleanse the skin thoroughly before applying medication.
  • cover the entire affected area with a thin layer one to three times a day.
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • wash hands after use.

Other information

STORAGE AND HANDLING SECTION

store in a cool dry place.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Glycerin, Isohexadecane, Butylene Glycol, Steareth-2, PEG-8, Lauryl Methacrylate/Glycol Dimethacrylate Crosspolymer, Cyclopentasiloxane, Cyclohexasiloxane, Polyacrylamide, Steareth-21, C13-14 Isoparaffin, Xanthan Gum, Laureth-7, Glyceryl Acrylate/Acrylic Acid Copolymer, Propylene Glycol, Fragrance, Sodium Hydroxide, Tetrasodium EDTA, Methylparaben, Propylparaben.

SPL UNCLASSIFIED SECTION

Ultra® Rapid Action Treatment Cream

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 10%

Purpose

OTC - PURPOSE SECTION

Acne Medication

Use

INDICATIONS & USAGE SECTION

for the treatment and prevention of acne pimples.

Warnings

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use if you have very sensitive skin or are sensitive to benzoyl peroxide.

When using this product

OTC - WHEN USING SECTION

  • avoid unnecessary sun exposure and use a sunscreen.
  • avoid contact with the eyes, lips and mouth.
  • avoid contact with hair or dyed fabrics, including carpet and clothing which may be bleached by this product.
  • with other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one medication should be used unless directed by a doctor.
  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. More frequent use or higher concentrations may aggravate skin irritation. Mild irritation may be reduced by using the product less frequently or in a lower concentration.

OTC - STOP USE SECTION

Stop use and ask a doctor if skin irritation becomes severe.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • follow Step 3 evening application by applying a thin layer to your acne pimples. Because excessive drying may occur, start with nightly application for the first 3 nights then reduce application to as needed.
  • if going outside, use a sunscreen. Allow Clearasil Ultra® Rapid Action Treatment Cream to dry, then follow directions in sunscreen labeling. If irritation or sensitivity develops, discontinue use of both products and consult a doctor.

Other information

STORAGE AND HANDLING SECTION

  • keep tightly closed.
  • keep away from heat.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Gluconolactone, Glyceryl Stearate, Clycerin, PEG-40 Stearate, PEG-100 Stearate, Cetyl Alcohol, Dimethicone, Magnesium Aluminum Silicate, Xantham Gum, Phenoxyethanol, Ammonium Hydroxide, Isopropylparaben, Butylparaben, Isobutylparaben, Arginine, Titanium Dioxide.

Questions? Comments?

OTC - QUESTIONS SECTION

Call 1-866-25-CLEAR (1-866-252-5327)

SPL UNCLASSIFIED SECTION

Distributed by: Reckitt Benckiser Inc.
Parsippany, NJ 07054-0224

Ultra® Rapid Action Daily Face Wash made in France
Ultra ® Rapid Action Daily Toner made in France
Ultra ® Rapid Action Daily Lotion made in USA
Ultra ® Rapid Action Treatment Cream made in USA

PRINCIPAL DISPLAY PANEL - Kit Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rapid Action
Acne Solution System

Clearasil®
ULTRA®

VISIBLY CLEARER SKIN
IN AS LITTLE AS*
4
HOURS

BONUS

*Ultra ® Rapid Action Treatment Cream
0.45 OZ. (13 g)

Ultra® Rapid Action Daily Face Wash
5 FL. OZ. (150 mL)

Ultra® Rapid Action Daily Toner
5 FL. OZ. (150 mL)

Ultra® Rapid Action Daily Lotion
1.5 FL. OZ. (45 mL)

PRINCIPAL DISPLAY PANEL - Kit Carton
PRINCIPAL DISPLAY PANEL - Kit Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Benzoyl PeroxideACTIVE INGREDIENTW9WZN9A0GM1
Salicylic AcidACTIVE INGREDIENTO414PZ4LPZ1
Benzoyl PeroxideACTIVE MOIETYW9WZN9A0GM1
Salicylic AcidACTIVE MOIETYO414PZ4LPZ1
AlcoholINACTIVE INGREDIENT3K9958V90M1
AmmoniaINACTIVE INGREDIENT5138Q19F1X1
ArginineINACTIVE INGREDIENT94ZLA3W45F1
Butylated HydroxytolueneINACTIVE INGREDIENT1P9D0Z171K1
Butylene GlycolINACTIVE INGREDIENT3XUS85K0RA1
ButylparabenINACTIVE INGREDIENT3QPI1U3FV81
C13-14 IsoparaffinINACTIVE INGREDIENTE4F12ROE701
Cetyl AlcoholINACTIVE INGREDIENT936JST6JCN1
Cetyl BetaineINACTIVE INGREDIENTE945X08YA91
Cyclomethicone 5INACTIVE INGREDIENT0THT5PCI0R1
Cyclomethicone 6INACTIVE INGREDIENTXHK3U310BA1
DimethiconeINACTIVE INGREDIENT92RU3N3Y1O1
Distearyldimonium ChlorideINACTIVE INGREDIENTOM9573ZX3X1
DocosanolINACTIVE INGREDIENT9G1OE216XY1
Edetate DisodiumINACTIVE INGREDIENT7FLD91C86K1
Edetate SodiumINACTIVE INGREDIENTMP1J8420LU1
GluconolactoneINACTIVE INGREDIENTWQ29KQ9POT1
GlycerinINACTIVE INGREDIENTPDC6A3C0OX1
Glyceryl MonostearateINACTIVE INGREDIENT230OU9XXE41
IsobutylparabenINACTIVE INGREDIENT0QQJ25X58G1
IsohexadecaneINACTIVE INGREDIENT918X1OUF1E1
IsopropylparabenINACTIVE INGREDIENTA6EOX47QK01
Laureth-7INACTIVE INGREDIENTZ95S6G82011
Lauryl Methacrylate/Glycol Dimethacrylate CrosspolymerINACTIVE INGREDIENTEX0F4CZ66H1
Magnesium Aluminum SilicateINACTIVE INGREDIENT6M3P64V0NC1
MentholINACTIVE INGREDIENTL7T10EIP3A1
MethylparabenINACTIVE INGREDIENTA2I8C7HI9T1
PEG-100 StearateINACTIVE INGREDIENTYD01N1999R1
PEG-40 StearateINACTIVE INGREDIENTECU18C66Q71
PhenoxyethanolINACTIVE INGREDIENTHIE492ZZ3T1
Polyethylene Glycol 400INACTIVE INGREDIENTB697894SGQ1
PPG-15 Stearyl EtherINACTIVE INGREDIENT1II18XLS1L1
Propylene GlycolINACTIVE INGREDIENT6DC9Q167V31
PropylparabenINACTIVE INGREDIENTZ8IX2SC1OH1
Sodium ChlorideINACTIVE INGREDIENT451W47IQ8X1
Sodium HydroxideINACTIVE INGREDIENT55X04QC32I1
Sodium Lauryl SulfateINACTIVE INGREDIENT368GB5141J1
Steareth-2INACTIVE INGREDIENTV56DFE46J51
Steareth-21INACTIVE INGREDIENT53J3F32P581
Stearyl AlcoholINACTIVE INGREDIENT2KR89I4H1Y1
Titanium DioxideINACTIVE INGREDIENT15FIX9V2JP1
WaterINACTIVE INGREDIENT059QF0KO0R1
Xanthan GumINACTIVE INGREDIENTTTV12P4NEE1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 60 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63824-35463824-354-00
63824-30963824-309-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 65 matching rows.

Name, UNII, Kind table
NameUNIIKind
Salicylic AcidO414PZ4LPZACTIB
Water059QF0KO0RIACT
PPG-15 Stearyl Ether1II18XLS1LIACT
GlycerinPDC6A3C0OXIACT
Stearyl Alcohol2KR89I4H1YIACT
Cetyl BetaineE945X08YA9IACT
Distearyldimonium ChlorideOM9573ZX3XIACT
Sodium Lauryl Sulfate368GB5141JIACT
Cetyl Alcohol936JST6JCNIACT
Alcohol3K9958V90MIACT
Steareth-2153J3F32P58IACT
Sodium Chloride451W47IQ8XIACT
Docosanol9G1OE216XYIACT
Steareth-2V56DFE46J5IACT
MENTHOL, UNSPECIFIED FORML7T10EIP3AIACT
Edetate Disodium7FLD91C86KIACT
Butylated Hydroxytoluene1P9D0Z171KIACT
Water059QF0KO0RINGR
Aloe Vera LeafZY81Z83H0XINGR
Tetradonium Bromide8483H94W1EINGR
Ceteareth-127V4MR24V5PINGR
Disodium Cocoamphodiacetate18L9G3U51MINGR
Sodium Chloride451W47IQ8XINGR
Allantoin344S277G0ZINGR
Chlorhexidine GluconateMOR84MUD8EINGR
Tartaric AcidW4888I119HINGR
ImidureaM629807ATLINGR
MethylparabenA2I8C7HI9TINGR
PropylparabenZ8IX2SC1OHINGR
Salicylic AcidO414PZ4LPZACTIB
Water059QF0KO0RIACT
GlycerinPDC6A3C0OXIACT
Isohexadecane918X1OUF1EIACT
Butylene Glycol3XUS85K0RAIACT
Steareth-2V56DFE46J5IACT
Polyethylene Glycol 400B697894SGQIACT
Lauryl Methacrylate/Glycol Dimethacrylate CrosspolymerEX0F4CZ66HIACT
Cyclomethicone 50THT5PCI0RIACT
Cyclomethicone 6XHK3U310BAIACT
Steareth-2153J3F32P58IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 19 · 1,103 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
Cyclomethicone 5CYCLOMETHICONE 50THT5PCI0RAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
3 equally ranked IID candidates
Cetyl AlcoholCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii candidate
20 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADERMALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRATHECAL1.35 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR7.01 mgExact identifier — unii candidate
174 equally ranked IID candidates
Sodium Lauryl SulfateSODIUM LAURYL SULFATE368GB5141JINSERT / VAGINAL15 mgExact identifier — unii candidate
42 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SUSPENSION / SOFT TISSUEADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, SUSPENSION / SUBCUTANEOUS1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KINJECTION / INTRAMUSCULAR10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAMUSCULAR0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IFILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
174 equally ranked IID candidates
PropylparabenPROPYLPARABENZ8IX2SC1OHSOLUTION / RESPIRATORY (INHALATION)0.01 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
PropylparabenPROPYLPARABENZ8IX2SC1OHSOLUTION / RECTAL0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
PropylparabenPROPYLPARABENZ8IX2SC1OHDROPS / NASAL14 mgExact identifier — unii candidate
68 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KINJECTION / INTRACARDIAC2 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAMUSCULAR78 mgExact identifier — unii candidate
174 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSPRAY, METERED / NASAL13 mgExact identifier — unii candidate
75 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TCREAM / TOPICAL3000 mgExact identifier — unii candidate
79 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, EMULSION / INTRAVENOUS24100 mgExact identifier — unii candidate
75 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM, AUGMENTED / TOPICAL0.2 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KSOLUTION / RESPIRATORY (INHALATION)43 mgExact identifier — unii candidate
77 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TSUSPENSION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TLOTION / TOPICAL351 mgExact identifier — unii candidate
79 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INFILTRATION3535 mgExact identifier — unii candidate
134 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR0.86 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XSOLUTION / AURICULAR (OTIC)18 mgExact identifier — unii candidate
134 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXDROPS / NASAL10 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR360 mgExact identifier — unii candidate
134 equally ranked IID candidates
Cyclomethicone 5CYCLOMETHICONE 50THT5PCI0RAEROSOL / TOPICAL2.5 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii candidate
40 equally ranked IID candidates
MentholMENTHOLL7T10EIP3ACREAM / TOPICAL0.1 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
Glyceryl MonostearateGLYCERYL MONOSTEARATE230OU9XXE4TABLET / SUBLINGUAL1.23 mgExact identifier — unii candidate
21 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE PELLETS / ORAL24 mgExact identifier — unii candidate
40 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / INTRATHECALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SPRAY / SUBLINGUAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
MethylparabenMETHYLPARABENA2I8C7HI9TINJECTION / EPIDURAL1 mgExact identifier — unii candidate
79 equally ranked IID candidates
MentholMENTHOLL7T10EIP3APOWDER, FOR SOLUTION / ORALNAExact identifier — unii candidate
24 equally ranked IID candidates
Butylated HydroxytolueneBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
32 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KLIQUID / NASAL2 mg/1mlExact identifier — unii candidate
77 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3EMULSION / OPHTHALMIC1.5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / PARENTERAL210 mgExact identifier — unii candidate
134 equally ranked IID candidates
Glyceryl MonostearateGLYCERYL MONOSTEARATE230OU9XXE4CAPSULE / ORAL13.75 mgExact identifier — unii candidate
21 equally ranked IID candidates
Propylene GlycolPROPYLENE GLYCOL6DC9Q167V3SHAMPOO, SUSPENSION / TOPICAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
Sodium ChlorideSODIUM CHLORIDE451W47IQ8XINJECTION / INTRA-ARTICULAR26 mgExact identifier — unii candidate
134 equally ranked IID candidates
Glyceryl MonostearateGLYCERYL MONOSTEARATE230OU9XXE4SUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
Sodium Lauryl SulfateSODIUM LAURYL SULFATE368GB5141JOINTMENT / TOPICAL14 mgExact identifier — unii candidate
42 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / INTRAVASCULARADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ArginineARGININE94ZLA3W45FTABLET, FILM COATED / ORAL25 mgExact identifier — unii candidate
11 equally ranked IID candidates
Edetate DisodiumEDETATE DISODIUM7FLD91C86KINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS6 mgExact identifier — unii candidate
77 equally ranked IID candidates
Sodium HydroxideSODIUM HYDROXIDE55X04QC32IOINTMENT / TOPICALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
4db3d873-76af-488c-a965-fa3e47b0983895a291e4-a967-4f32-9a16-8a7db90ba91e2019-08-29WarningsExact identifier
spl id: 4db3d873-76af-488c-a965-fa3e47b09838
spl set id: 95a291e4-a967-4f32-9a16-8a7db90ba91e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.